Shorter radiation course stops cancer growth in high-risk prostate cancer patients
Hypofractionated radiation treatment, a newer type of radiation treatment that delivers higher doses of radiation in fewer treatments than conventional radiation therapy, is significantly more effective in stopping cancer from growing in high risk patients, compared to receiving standard radiation treatment, according to a study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO). In addition, findings show there is no increased risk of negative side effects later in patients who undergo hypofractionated radiation. "The study not only shows that hypofractionated radiation improves the control of prostate cancer, but it also cuts the number of treatment visits in half for patients. This is an important benefit for these high-risk patients, who are typically an older, less mobile population," Giorgio Arcangeli, M.D., lead author of the study and a radiation oncologist at the Regina Elena National Cancer Institute in Rome, Italy said. "It's also especially helpful for those living at long distance from radiation treatment centers."
All men in the study were treated with three-dimensional conformal radiation therapy, or 3D-CRT. It is a type of external beam radiation therapy that uses computers and special imaging techniques to show the size, shape and location of the tumor as well as surrounding organs to precisely tailor the radiation beams to the size and shape of the tumor. Because the radiation beams are very precisely directed, nearby normal tissue receives less radiation and is able to heal more quickly.
During external beam radiation therapy, a beam of radiation is directed through the skin to the cancer and the immediate surrounding area in order to destroy the main tumor and any nearby cancer cells.
From January 2003 to December 2007, a total of 168 high risk prostate cancer patients were randomized to receive either hypofractionated or conventional schedules of 3D-CRT to the prostate and surrounding area. Patients who received hypofractionated radiation had only 20 sessions of radiation (four weeks of daily radiation therapy treatments), instead of the 40 to 45 (eight to nine weeks of daily treatments) sessions typically required during standard radiation treatment.
Study findings show that the patients treated with hypofractionated radiation had a better chance (87 percent vs. 79 percent) that their cancer would stop growing, compared to patients treated with standard radiation therapy. There was also no difference in the late side effects of genito-urinary and gastro-intestinal function between the two groups of patients.
"Studies are in progress to test the benefits of even shorter treatment schedules," Dr. Arcangeli said.
Source: American Society for Radiation Oncology
Articles on the same topic
- Time between treatment and PSA recurrence predicts death from prostate cancerWed, 4 Nov 2009, 20:09:57 UTC
- Radiation therapy after lumpectomy for breast cancer can be safely reduced to 4 weeksWed, 4 Nov 2009, 18:11:33 UTC
- 3-week course of breast radiation may be as effective as conventional 5- to 7-week course for early breast cancersWed, 4 Nov 2009, 18:11:32 UTC
- Does race, income predict prostate cancer outcome?Wed, 4 Nov 2009, 17:31:18 UTC
- Cancer patients want honesty, compassion from their oncologistWed, 4 Nov 2009, 17:31:15 UTC
- Shorter radiation course as effective as standard therapy for prostate cancer recurrenceTue, 3 Nov 2009, 18:26:29 UTC
- Radiation therapy technique successfully treats pain in patients with advanced cancerTue, 3 Nov 2009, 16:08:59 UTC
- PET imaging before radiation not ideal for determining boost radiation dosesTue, 3 Nov 2009, 15:46:33 UTC
- Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patientsMon, 2 Nov 2009, 18:24:29 UTC
- Proton therapy is well-tolerated in prostate cancer patientsMon, 2 Nov 2009, 17:59:49 UTC
- Stereotactic radiotherapy stops lung cancer from growing in frail patientsMon, 2 Nov 2009, 17:44:13 UTC
- Stereotactic radiotherapy stops lung cancer from growing in frail patientsMon, 2 Nov 2009, 17:44:11 UTC
- Stereotactic radiotherapy offers noninvasive, effective treatment for lung cancer patientsMon, 2 Nov 2009, 17:44:10 UTC
- Adding proton therapy 'boost' to X-ray radiation therapy reduces prostate cancer recurrencesMon, 2 Nov 2009, 17:39:33 UTC
- Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancerMon, 2 Nov 2009, 17:15:37 UTC
- Preventative brain radiation for lung cancer patients: Benefits and risksMon, 2 Nov 2009, 16:51:41 UTC
- Undetectable PSA after radiation is possible and predicts good patient outcomesMon, 2 Nov 2009, 16:33:07 UTC
- Additional, specialized radiation not necessary for some women after mastectomyMon, 2 Nov 2009, 16:33:05 UTC
- Real benefits vs. risks of preventative brain radiation for nonsmall cell lung cancer patientsMon, 2 Nov 2009, 16:33:04 UTC
- Radiation after surgery reduces chance of melanoma returningMon, 2 Nov 2009, 16:33:03 UTC
- Short-term hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patientsMon, 2 Nov 2009, 16:33:00 UTC
Other sources
- Irradiated cancers stay downfrom Science AlertThu, 5 Nov 2009, 8:14:23 UTC
- Radiation therapy after lumpectomy for breast cancer can be safely reduced to 4 weeksfrom PhysorgWed, 4 Nov 2009, 21:28:05 UTC
- Cancer patients want honesty, compassion from their oncologistfrom PhysorgWed, 4 Nov 2009, 19:14:06 UTC
- Radiation therapy technique successfully treats pain in patients with advanced cancerfrom Science BlogTue, 3 Nov 2009, 21:07:19 UTC
- PET imaging before radiation not ideal for determining boost radiation dosesfrom PhysorgTue, 3 Nov 2009, 19:56:11 UTC
- Radiation Therapy Technique Successfully Treats Pain In Patients With Advanced Cancerfrom Science DailyTue, 3 Nov 2009, 17:21:13 UTC
- Radiation therapy technique successfully treats pain in patients with advanced cancerfrom PhysorgTue, 3 Nov 2009, 16:35:53 UTC
- Additional, specialized radiation not necessary for some women after mastectomyfrom PhysorgTue, 3 Nov 2009, 7:56:07 UTC
- Adding proton therapy 'boost' to X-ray radiation therapy reduces prostate cancer recurrencesfrom PhysorgTue, 3 Nov 2009, 4:56:07 UTC
- Proton Therapy Is Well-tolerated In Prostate Cancer Patientsfrom Science DailyTue, 3 Nov 2009, 4:14:07 UTC
- Stereotactic radiotherapy stops lung cancer from growing in frail patientsfrom PhysorgTue, 3 Nov 2009, 3:28:16 UTC
- Preventative brain radiation for lung cancer patients: Benefits and risksfrom PhysorgTue, 3 Nov 2009, 3:28:14 UTC
- Proton therapy is well-tolerated in prostate cancer patientsfrom PhysorgTue, 3 Nov 2009, 1:14:18 UTC
- Undetectable PSA after radiation is possible and predicts good patient outcomesfrom PhysorgTue, 3 Nov 2009, 0:07:19 UTC
- Radiation after surgery reduces chance of melanoma returningfrom PhysorgMon, 2 Nov 2009, 22:56:16 UTC
- Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patientsfrom PhysorgMon, 2 Nov 2009, 21:49:15 UTC
- Preventative brain radiation for lung cancer patients: Benefits and risksfrom Science BlogMon, 2 Nov 2009, 18:49:09 UTC
- Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancerfrom PhysorgMon, 2 Nov 2009, 17:42:15 UTC
- Stereotactic Radiotherapy Offers Noninvasive, Effective Treatment for Frail Patients with Early-stage Lung Cancerfrom Newswise - ScinewsMon, 2 Nov 2009, 17:42:07 UTC
- Undetectable PSA After Radiation Is Possible And Predicts Good Patient Outcomesfrom Science DailyMon, 2 Nov 2009, 17:21:30 UTC
- Radiation After Surgery Reduces Chance Of Melanoma Returningfrom Science DailyMon, 2 Nov 2009, 16:28:58 UTC